Purchase of AAA Netspot — Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours
A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE ROYAL MARSDEN NHS FOUNDATION TRUSTS
- Source
- OJEU
- Type
- Contract (Supply)
- Duration
- not specified
- Value
- £475K
- Sector
- HEALTH
- Published
- 20 Apr 2021
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
London
Geochart for 2 buyers and 2 suppliers
2 buyers
- Royal Marsden NHS Trusts London
1 supplier
Description
AAA Netspot is a diagnostic imaging agent kit to detect neuroendocrine tumours.
Total Quantity or Scope
The Royal Marsden Hospital NHS Foundation Trust needs to purchase AAA Netspot vials which is a Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours.
Award Detail
| 1 | Advance Accelerator Applications (London)
|
| 2 | Advance Accelerator Applications (London)
|
CPV Codes
- 33000000 - Medical equipments, pharmaceuticals and personal care products
Indicators
Legal Justification
AAA Netspot vials is a diagnostic imaging agent kit to detect neuroendocrine tumours. A radioactive diagnostic agent for positron emission tomography (PET) imaging of somatostatin receptor overexpression in adult patients with confirmed or suspected somatostatin receptor positive Neuroendocrine tumors (NETs) for localizing primary tumours and their metastases. This innovative technology supports a more accurate diagnosis and staging of NETs and a more tailored treatment plan.
Reference
- OJEU 195846-2021